(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Trichostrongyloidiasis D014252 7 associated lipids
Trematode Infections D014201 8 associated lipids
Thyrotoxicosis D013971 3 associated lipids
Thinness D013851 11 associated lipids
Syndrome D013577 4 associated lipids
Stomach Diseases D013272 7 associated lipids
Status Epilepticus D013226 1 associated lipids
Starvation D013217 47 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Spasms, Infantile D013036 3 associated lipids
Sleep Deprivation D012892 5 associated lipids
Short Bowel Syndrome D012778 3 associated lipids
Shock D012769 11 associated lipids
Sheep Diseases D012757 10 associated lipids
Seizures D012640 87 associated lipids
Sandhoff Disease D012497 2 associated lipids
Reye Syndrome D012202 14 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Puerperal Disorders D011644 4 associated lipids
Pregnancy Complications D011248 19 associated lipids
Plant Poisoning D010939 5 associated lipids
Placental Insufficiency D010927 6 associated lipids
Parvoviridae Infections D010322 4 associated lipids
Parkinson Disease, Secondary D010302 17 associated lipids
Parkinson Disease D010300 53 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pallor D010167 1 associated lipids
Obesity, Morbid D009767 8 associated lipids
Obesity D009765 29 associated lipids
Neural Tube Defects D009436 5 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Muscle Rigidity D009127 4 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Metabolic Diseases D008659 12 associated lipids
Mastitis, Bovine D008414 8 associated lipids
Mastitis D008413 3 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Diseases D008171 37 associated lipids
Liver Diseases D008107 31 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Lipoma D008067 1 associated lipids
Lipidoses D008064 7 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Lacrimal Apparatus Diseases D007766 1 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Ketosis D007662 13 associated lipids
Kearns-Sayre Syndrome D007625 2 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Larsen S et al. The effect of insulin withdrawal on intermediary metabolism in patients with diabetes secondary to chronic pancreatitis. 1991 Acta Endocrinol. pmid:2028708
Gillmer MD et al. Low energy diets in the treatment of gestational diabetes. 1986 Acta Endocrinol Suppl (Copenh) pmid:3532669
Aarsen RS et al. Long-acting somatostatin analogue (Sandostatin) reduces late night insulinopenic ketogenesis in diabetic teenagers. 1987 Acta Endocrinol Suppl (Copenh) pmid:2892337
Avogaro A et al. Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes. 1990 Jan-Mar Acta Diabetol Lat pmid:2336923
Al-Awadi F and Shoukry M The lipid lowering effect of an anti-diabetic plant extract. 1988 Jan-Mar Acta Diabetol Lat pmid:3407374
Stangenberg M et al. Effect of treatment with insulin or diet on intermediary metabolites in pregnant women with chemical diabetes in the third trimester of pregnancy. 1984 Jan-Mar Acta Diabetol Lat pmid:6375226
Micossi P et al. Metabolic instability in type I diabetic patients. Studies on insulin absorption, hepatic production of metabolites and glucose counterregulation. 1985 Jul-Sep Acta Diabetol Lat pmid:3907236
Gregorio F et al. Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations. 1990 Apr-Jun Acta Diabetol Lat pmid:2198745
Hoque MM et al. Structure of D-3-hydroxybutyrate dehydrogenase prepared in the presence of the substrate D-3-hydroxybutyrate and NAD+. 2009 Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. pmid:19342772
Faria MH et al. Ketone bodies metabolism during ischemic and reperfusion brain injuries following bilateral occlusion of common carotid arteries in rats. 2007 Mar-Apr Acta Cir Bras pmid:17375219